Menu
About Us
Overview
Board
Team
Corporate Directory
Our Science
Gene Silencing
Intellectual Property
Partnering
Our Programs
Areas of Research
Pipeline
Out-Licensed Programs
Presentations and Publications
For Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Contact Us
Quarterly Reports
Investors
Investors
Overview
News & Events
Overview
Press Releases
Events
Media Coverage
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Annual Reports
Form 8937 – Reverse Stock Split
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-Q
Year:
View All
2024
2023
2022
2021
2020
Date
Form
Description
PDF
XBRL
Pages
11/13/20
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-31.1
EX-31.2
EX-32.1
EX-32.2
38
Previous
1
2
Email Alerts
Contacts
RSS News Feed
